Sung Sik Bang

Title: Innovations of Sung Sik Bang in Gene Medicine Delivery

Introduction

Sung Sik Bang is an accomplished inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of gene medicine through his innovative research and development. His work focuses on creating effective delivery systems for gene therapies, which are crucial for advancing medical treatments.

Latest Patents

Sung Sik Bang holds a patent for a "Chitosan based polymer conjugate and a method for producing the same." This invention relates to a conjugate of chitosan and polyamine polymer that is useful for transferring desired gene medicine into cells. The patent describes a double conjugate prepared by linking poly-L-arginine to low molecular weight chitosan, as well as a triple conjugate that includes polyethylene glycol (PEG). The chitosan-based cationic polymer conjugate forms a complex with negatively charged gene medicines, such as plasmid DNA and small interfering RNA, allowing for efficient transfer into cells with low cytotoxicity. This innovative delivery system is poised to enhance the in vivo administration of gene medicine.

Career Highlights

Sung Sik Bang has established himself as a key figure in the field of gene therapy. His work at Engene, Inc. has allowed him to collaborate with other talented professionals in the industry. His dedication to research and development has led to advancements that could significantly impact medical treatments.

Collaborations

Sung Sik Bang has worked alongside notable colleagues, including Myung-Ok Park and Yu-Kyoung Oh. Their combined expertise has contributed to the success of their projects and the advancement of gene medicine technologies.

Conclusion

Sung Sik Bang's innovative work in developing chitosan-based polymer conjugates represents a significant advancement in gene medicine delivery systems. His contributions are expected to play a vital role in the future of medical treatments.